MarketVector™ Bioproduction Tech and Tools ESG Index
The MarketVector™ Bioproduction Tech and Tools ESG Index tracks the performance of the largest and most liquid global companies involved in the development of technologies, tools, materials, and processes related to the development or manufacture of biopharmaceuticals. This is a modified market cap-weighted index, and includes companies that generate at least 50% of their revenue from bioproduction and the following products and services related to the bioproduction industry: laboratory technologies, contract research, contract manufacturing, and clinical diagnostics. MVBIOP covers at least 98% of the investable universe and adheres to ESG criteria.
Key Features
| Size and Liquidity Requirements | Full MCap of at least 150 mln USD.
Three month average-daily-trading volume of at least 1 mln USD at a review and also at the previous two reviews.
At least 250,000 shares traded per month over the last six months at a review and also at the previous two reviews. |
| Universe | Companies have to generate at least 50% revenues from products and services related to the bioproduction industry. |
| Diversification | Company weights are capped at 5%. |
| Review | Quarterly. |
Timescale Slider
| Symbol |
IndexName |
| MVBIOP |
MarketVector™ Bioproduction Tech and Tools ESG Price Index |
| MVBIOPTR |
MarketVector™ Bioproduction Tech and Tools ESG Total Return Net Index |
